Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Stilbene paste capsule of rising white blood cell for curing disease of leucopenia

A technology of leukopenia and Shengbai capsules, which is applied in the fields of extracellular fluid diseases, blood diseases, capsule delivery, etc., can solve the problems of drug side effects, price, inconvenient taking, poor taste, etc., and achieve remarkable curative effect, safe and convenient taking, low price effect

Inactive Publication Date: 2003-05-07
贵州汉方药业有限公司
View PDF0 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] At present, in the prior art, there are many medicines for treating leukopenia diseases, and these medicines generally have certain curative effect, but most medicines are in ointment type, which has the disadvantages of inconvenient taking and poor mouthfeel, and some medicines also have Certain side effects and expensive problems

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0006] Example 1 of the present invention: take 225 grams of jujube, 225 grams of donkey-hide gelatin, 337 grams of blood ginseng, 337 grams of epimedium, 225 grams of sophora flavescens, 735 grams of astragalus, and 225 grams of angelica. The traditional Chinese patent medicine capsule dosage form can be made into capsule dosage form, or the angelica is first crushed into fine powder for later use, and the remaining medicinal materials except donkey-hide gelatin are decocted with water for 2 to 4 times, each time for 1 to 3 hours, combined and filtered The filtrate is obtained by decocting the gelatin, melted and combined with the filtrate, the combined filtrate is concentrated to an extract with a specific gravity of 1.30 at a temperature of 80°C, the extract is mixed evenly with Angelica fine powder, and then dried. The dried raw materials are pulverized into coarse powder and packed into capsules in an amount of 0.5 g per grain to obtain the finished product.

Embodiment 2

[0007] Embodiment 2 of the present invention: get 275 grams of jujube, 275 grams of donkey-hide gelatin, 412 grams of blood ginseng, 412 grams of epimedium, 275 grams of sophora flavescens, 825 grams of astragalus, and 275 grams of angelica, and first crush the angelica into fine powder for subsequent use. Decoct the rest of the medicinal materials except donkey-hide gelatin with water for 2-4 times, each time for 1-3 hours, combine and filter the decoction to obtain the filtrate, melt the donkey-hide gelatin and combine with the filtrate, and concentrate the combined filtrate to a temperature of 80°C The specific gravity is 1.30 extract, the extract is mixed evenly with angelica fine powder, and then dried, and then the dried raw material is crushed into coarse powder, and then packed into capsules in an amount of 0.5 g per capsule to obtain the finished product.

Embodiment 3

[0008] Embodiment 3 of the present invention: get 250 grams of jujube, 250 grams of donkey-hide gelatin, 375 grams of blood ginseng, 375 grams of epimedium, 250 grams of sophora flavescens, 750 grams of astragalus, and 250 grams of angelica, and first grind the angelica into fine powder for subsequent use. Decoct the rest of the medicinal materials except donkey-hide gelatin with water for 2-4 times, each time for 1-3 hours, combine and filter the decoction to obtain the filtrate, melt the donkey-hide gelatin and combine with the filtrate, and concentrate the combined filtrate to a temperature of 80°C The specific gravity is 1.30 extract, the extract is mixed evenly with angelica fine powder, and then dried, and then the dried raw material is crushed into coarse powder, and then packed into capsules in an amount of 0.5 g per capsule to obtain the finished product.

[0009] The usage and dosage of its finished product are: oral administration, 3 times a day, 4 capsules each time...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A Chinese medicine in the form of capsule for treating leukocytopenia, dizziness, cold, etc is prepared from 7 Chinese-medicinal materials including jujube, donkey-hide gelatin, astragalus root, Chinese angelica root, etc. Its advantages are high curative effect and no toxic by-effect.

Description

Technical field: [0001] The invention relates to a Qijiao Shengbai capsule for treating leukopenia, belonging to the technical field of drugs for treating leukopenia. Background technique: [0002] At present, in the prior art, there are many medicines for treating leukopenia diseases, and these medicines generally have certain curative effect, but most medicines are in ointment type, which has the disadvantages of inconvenient taking and poor mouthfeel, and some medicines also have Certain side effects and expensive problems. Invention content: [0003] The purpose of the present invention is to provide a Qijiao Shengbai Capsule for treating leukopenia with good curative effect, no toxic and side effects, safe and convenient to take, and low price, so as to overcome the shortcomings of existing medicines. [0004] The present invention is achieved in the following way: it is made into a capsule dosage form finished product from 7 Chinese herbal medicines of jujube, donke...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/48A61K35/36A61P7/00
Inventor 吴建滨
Owner 贵州汉方药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products